NCT00823693

Brief Summary

The purpose of this study is to determine whether Bimosiamose Cream is safe and effective in the treatment of plaque type psoriasis.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
107

participants targeted

Target at P50-P75 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 14, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 16, 2009

Completed
Last Updated

August 21, 2009

Status Verified

August 1, 2009

First QC Date

January 14, 2009

Last Update Submit

August 20, 2009

Conditions

Psoriasis

Study Arms (2)

Bimosiamose Cream

ACTIVE COMPARATOR
Drug: Bimosiamose Cream

Placebo Cream

PLACEBO COMPARATOR
Drug: Placebo Cream

Interventions

Bimosiamose CreamDRUG
Bimosiamose Cream
Placebo CreamDRUG
Placebo Cream

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of plaque type psoriasis PASI score of 5-15
  • At least 18 years of age
  • Written informed consent

You may not qualify if:

  • Active skin infection
  • More than 20% Body Surface Area (BSA) affected by psoriasis
  • Use of certain anti-psoriasis medication or treatments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Charité Campus Mitte, Klinik für Dermatologie, Venerologie und Allergologie

Berlin, Germany

Location

MeSH Terms

Conditions

Psoriasis

Condition Hierarchy (Ancestors)

Skin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

January 14, 2009

First Posted

January 16, 2009

Last Updated

August 21, 2009

Record last verified: 2009-08

Locations

DE(1)